References
- Goessens W. H. F., Mouton J. W., van der Meijden W. I., Deelen S., van Rijsoort‐Vos T. H., Lemmens‐den Toom N., et al. Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first‐void urine. J Clin Microbiol 1997; 35: 2628–33
- Crotchfelt K. A., Pare B., Gaydos C., Quinn T. C. Detection of Chlamydia trachomatis by the Gen‐Probe AMPLIFIED Chlamydia trachomatis assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J Clin Microbiol 1998; 36: 391–4
- Poulakkainen M., Hiltunen‐Back E., Reunala T., Suhonen S., Lähteenmäki P., Lehtinen M., et al. Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection. J Clin Microbiol 1998; 36: 1489–93
- van der Pool B., Ferrero D. V., Buck‐Barrington L., Hook E I. I. I., Lenderman C., Quinn T., et al. Multicenter evaluation of the BDProbeTec ET system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol 2001; 39: 1008–16
- Ripa K. T., Mårdh P‐A. Cultivation of Chlamydia trachomatis in cycloheximide‐treated McCoy cells. J Clin Microbiol 1977; 6: 328–31
- Cook R. L., Hutchison S. L., Ostergaard L., Braithwaite R. S. Ness RB. Systematic review: non‐invasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005; 142: 914–25
- Mahoney J., Chong S., Jang D., Lunistra K., Faught K., Dalby D., et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 1998; 36: 3122–6
- Bowden F. J. Reappraising the value of urine leukocyte esterase testing in the age of nucleic acid amplification. Sex Transmit Dis 1998; 25: 322–6
- Hedin G., Abrahamsson G., Dahlberg E. Urethritis associated with Chlamydia trachomatis: comparison of leukocyte esterase dipstick test of first‐voided urine and methylene blue‐stained urethral smear as predictors of chlamydial infection. APMIS 2001; 109: 595–600
- Patrick D. M., Rekart M. L., Knowles L. Unsatisfactory performance of the leukocyte esterase test of first voided urine for rapid diagnosis of urethritis. Genitourin Med 1994; 70: 187–90
- Blake D. R., Lemay C. A., Gaydos C. A., Quinn T. C. Performance of urine leukocyte esterase in asymptomatic male youth: another look with nucleic acid amplification testing as the gold standard for Chlamydia detection. J Adolesc Health 2005; 36: 337–41
- Alary M., Lowndes C. M., Mukenge‐Tshibaka L., Gnintoungbé C. A. B., Bédard E., Geraldo N., et al. Sexually transmitted infections in male clients of female sex workers in Benin: risk factors and reassessment of the leucocyte esterase dipstick for screening of urethral infections. Sex Transm Infect 2003; 79: 388–92
- Chow J. M., Moncada J., Brooks D., Bolan G., Shaw H., Schachter J. Is urine leukocyte esterase test a useful screening method to predict Chlamydia trachomatis infection in women?. J Clin Microbiol 1996; 34: 534–6
- Ginocchio R. H. S., Veenstra D. L., Connell F. A., Marrazzo J. M. The clinical and economic consequences of screening young men for genital chlamydial infection. Sex Transm Dis 2003; 30: 99–106
- Mrus J. M., Biro F. M., Huang B., Tsevat J. Evaluating adolescents in juvenile detention facilities for urogenital chlamydial infections: cost and effectiveness of alternative interventions. Arch Pediatr Adolesc Med 2003; 157: 696–702